The in vivo studies indicated the role of AHI1 in mood disorders, showing that the knock-out of Ahi1 resulted in depressive-like behaviour and neurochemical changes in depression-related serotonin and dopamine levels in different brain regions (Ren et al. 2014; Wang et al. 2022). This evidence concerns the gene AHI1 and depressive disorder.